(GSA) SSA/EA/Rig eval (Pharm S&S)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract focuses on implementing enhanced evaluation strategies to design an effective pharmacist-led intervention aimed at improving hypertension control and expanding healthcare access. This initiative is overseen by the Centers for Disease Control and Prevention and emphasizes leveraging pharmacist expertise to better manage hypertension, which is a critical public health concern. By utilizing advanced evaluation methodologies, the project aims to optimize intervention approaches, ensuring more impactful outcomes in patient care. The contract is currently in the forecast stage, without specific solicitation details or set-aside designations provided. Key contacts for the project include Joanna Elmi, serving as the program point of contact, and a contracting officer yet to be determined. While the geographical scope and organizational types involved are not specified, the overall goal is to integrate pharmacist services more deeply into hypertension management frameworks, potentially enhancing healthcare delivery and accessibility on a broader scale.
General Info
Agency
NAICS
Place of Performance
USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
